Int. J. Mol. Sci. 2012, 13(8), 9627-9641; doi:10.3390/ijms13089627
Article

Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer

1 Department of Biochemistry and Molecular Biology, Bengbu Medical College, Bengbu 233030, China 2 Laboratory Medicine, Taixing People’s Hospital, Taizhou 225400, China 3 Research Center of Clinical Laboratory Science, Bengbu Medical College, Bengbu 233030, China 4 Department of Pathology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA 5 University of Mississippi Cancer Institute, 2500 N State St, Jackson, MS 39216, USA 6 Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 30 May 2012; in revised form: 15 July 2012 / Accepted: 25 July 2012 / Published: 2 August 2012
(This article belongs to the collection Programmed Cell Death and Apoptosis)
PDF Full-text Download PDF Full-Text [920 KB, uploaded 2 August 2012 13:18 CEST]
Abstract: Arsenic trioxide has been reported to inhibit cell growth and induce apoptotic cell death in many human cancer cells including breast cancer. However, the precise molecular mechanisms underlying the anti-tumor activity of arsenic trioxide are still largely unknown. In the present study, we assessed the effects of arsenic trioxide on cell viability and apoptosis in breast cancer cells. For mechanistic studies, we used multiple cellular and molecular approaches such as MTT assay, apoptosis ELISA assay, gene transfection, RT-PCR, Western blotting, and invasion assays. For the first time, we found a significant reduction in cell viability in arsenic trioxide-treated cells in a dose-dependent manner, which was consistent with induction of apoptosis and also associated with down-regulation of Notch-1 and its target genes. Taken together, our findings provide evidence showing that the down-regulation of Notch-1 by arsenic trioxide could be an effective approach, to cause down-regulation of Bcl-2, and NF-κB, resulting in the inhibition of cell growth and invasion as well as induction of apoptosis. These results suggest that the anti-tumor activity of arsenic trioxide is in part mediated through a novel mechanism involving inactivation of Notch-1 and its target genes. We also suggest that arsenic trioxide could be further developed as a potential therapeutic agent for the treatment of breast cancer.
Keywords: Notch; arsenic trioxide; NF-κB; breast cancer; apoptosis; cell growth

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Xia, J.; Li, Y.; Yang, Q.; Mei, C.; Chen, Z.; Bao, B.; Ahmad, A.; Miele, L.; Sarkar, F.H.; Wang, Z. Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer. Int. J. Mol. Sci. 2012, 13, 9627-9641.

AMA Style

Xia J, Li Y, Yang Q, Mei C, Chen Z, Bao B, Ahmad A, Miele L, Sarkar FH, Wang Z. Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer. International Journal of Molecular Sciences. 2012; 13(8):9627-9641.

Chicago/Turabian Style

Xia, Jun; Li, Youjian; Yang, Qingling; Mei, Chuanzhong; Chen, Zhiwen; Bao, Bin; Ahmad, Aamir; Miele, Lucio; Sarkar, Fazlul H; Wang, Zhiwei. 2012. "Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer." Int. J. Mol. Sci. 13, no. 8: 9627-9641.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert